This approach would be particularly useful for two main Tfr2α features; Tfr2α-selective expression in particular tissues (hepatic, erythroid, and in CNS) and Tfr2α high expression in several tumor cells, sometimes with Tfr1 and sometimes without it. The gene discussed is TFRC; the disease is neoplasm.